Spiroxamine

CAS No. 118134-30-8

Spiroxamine( —— )

Catalog No. M28102 CAS No. 118134-30-8

Spiroxamine is a tertiary amine fungicide and an inhibitor of δ14 reductase and δ8→δ7 isomerase. Spiroxamine inhibits the growth of N. parvum, B. dothidea, D. seriata, and L. theobromae isolates from grape vines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 63 Get Quote
25MG 102 Get Quote
50MG 150 Get Quote
100MG 223 Get Quote
500MG 557 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Spiroxamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Spiroxamine is a tertiary amine fungicide and an inhibitor of δ14 reductase and δ8→δ7 isomerase. Spiroxamine inhibits the growth of N. parvum, B. dothidea, D. seriata, and L. theobromae isolates from grape vines.
  • Description
    Spiroxamine is a tertiary amine fungicide and an inhibitor of δ14 reductase and δ8→δ7 isomerase. Spiroxamine inhibits the growth of N. parvum, B. dothidea, D. seriata, and L. theobromae isolates from grape vines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    118134-30-8
  • Formula Weight
    297.483
  • Molecular Formula
    C18H35NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCN(CC)CC1COC2(CCC(CC2)C(C)(C)C)O1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Guardigli A, Chow W, Lefar MS. Determination of carbetamide residues and its aniline metabolite. J Agric Food Chem. 1972 Mar-Apr;20(2):348-50.
molnova catalog
related products
  • MRT-2359

    MRT-2359 is a potent and orally available GSPT1 reducer with antitumour activity.MRT-2359 inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.MRT-2359 exhibits preferential activity in MYC-driven cell lines.

  • 5-Bromouracil

    5-Bromouracil disrupts nucleosome positioning by inducing A-form-like DNA.

  • Tortoside B (Manglie...

    Manglieside E significantly (p<0.05) increased the growth and differentiation of osteoblastic MC3T3-E1 cells.